What are the SGO guidelines on ovarian cancer prevention?

Updated: Aug 10, 2020
  • Author: Andrew E Green, MD; Chief Editor: Yukio Sonoda, MD  more...
  • Print

SGO guidelines are in agreement that women who have BRCA mutations should be offered RRSO, after completion of childbearing, as the best strategy for reducing their risk of developing ovarian cancer. The guidelines further recommend that for those women who choose not to undergo RRSO because of the health risks and impact on quality of life associated with premature menopause, physicians may offer the option of salpingectomy after childbearing is completed, followed by oophorectomy in the future. However, women who delay oophorectomy will remain at risk for developing ovarian cancer. Additionally, they will not benefit from the 50% reduction in breast cancer provided through premenopausal oophorectomy. [130]

The SGO advises that pathologic processing of RRSO specimens from high-risk women should include micro-sectioning of the ovaries and tubes, with special attention to the fimbriae. [130]

For women at average risk of ovarian cancer, risk-reducing salpingectomy should also be considered at the time of abdominal or pelvic surgery or hysterectomy or in lieu of tubal ligation. The pathologic specimen processing in low risk-women should include representative sections of the tube, any suspicious lesions, and entire sectioning of the fimbriae. [130]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!